Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
- Accession Number
- Not Available
Drug Drug Description Pegdinetanib Investigated for use/treatment in cancer/tumors (unspecified) and macular degeneration. Tesevatinib Tesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs... Golvatinib Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
- Drugs & Drug Targets
Drug Target Type Pegdinetanib Vascular endothelial growth factor receptor 2 target Tesevatinib Pro-epidermal growth factor target Tesevatinib Ephrin type-B receptor 4 target Tesevatinib Receptor tyrosine-protein kinase erbB-2 target